---
schema_version: "secwatch.filing_event.v1"
accession: "0000927653-24-000018"
form_type: "8-K"
ticker: "MCK"
cik: "0000927653"
company_name: "MCKESSON CORP"
filed_at: "2024-02-07T23:59:59+00:00"
generated_at: "2026-06-06T07:35:28.540670+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# McKesson FQ3 revenue $80.9B (+15% YoY), adjusted EPS $7.74 (+12%), raises FY guidance

## Summary
- Revenue $80.9B up 15% YoY; GAAP EPS from continuing ops $4.42 vs $7.65 (down 42%).
- Adjusted EPS $7.74 vs $6.90; adjusted earnings $1,032M up 6%.
- FY 2024 adjusted EPS guidance raised to $27.25-$27.65 from $26.80-$27.40.
- US Oncology Network added Nashville Oncology Associates and SCRI Oncology Partners.
- Year-to-date revenue $232.6B (+12%); adjusted EPS $21.24 (+13%).

## SEC filing metadata
- accession: 0000927653-24-000018
- form_type: 8-K
- ticker: MCK
- cik: 0000927653
- company_name: MCKESSON CORP
- filed_at: 2024-02-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927653/000092765324000018/0000927653-24-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927653/000092765324000018/mck-20240207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927653-24-000018
- JSON: https://secwatch.observer/filing/0000927653-24-000018.json
- Plain text: https://secwatch.observer/filing/0000927653-24-000018.txt

## Key facts
- Earnings Releases
  MCKESSON CORP reported the third quarter ended December 31, 2023 results: revenue $80,898, net income $589, EPS $4.42. Guidance raised.
  - Period: the third quarter ended December 31, 2023
  - Revenue: $80,898
  - Net income: $589
  - EPS: $4.42
  - Guidance: raised
  - Result: preliminary results
  source text: December 31, 2023. Fiscal 2024 Third Quarter Result Summary Third Quarter Year-to-Date ($ in millions, except per share amounts) FY24 FY23 Change FY24 FY23 Change Revenues $ 80,898 $ 70,490 15 % $ 232,596 $ 207,801 12 % Income from Continuing Operations 2 589 1,078 (45) 2,211 2,776 (20) Adjusted Earnings 2,3 1,032 972 6 2,866 2,697 6 Earnings per Diluted
  evidence_url: https://www.sec.gov/Archives/edgar/data/927653/000092765324000018/0000927653-24-000018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.